Go figure the hedge against AI infrastructure is actually LSD-based anxiety treatment $DFTX is 3 for 3 now on DT120 psychedelic therapy trials (2 for generalized anxiety disorder, and 1 for major depressive disorder) There is one more depression trial underway, and FDA has already issued breakthrough-therapy designation for DT120. Commercial rollout in early 2028 would be a reasonable target These trials are SINGLE DOSE, yet are proving to be an order-of-magnitude improvement over current FDA approved treatment offerings: a lifetime of daily SSRIs + therapy. This is a very welcome revolution in mental health treatment I say this a lot but there is nothing better than making money on an investment that is also going to improve the lives of millions of people
在 X 查看 ↗